Speedy weight loss from drugs used to fight obesity and diabetes has left some users looking gaunt and aged. The boss of Swiss skincare group Galderma thinks treatments for what has been dubbed “Ozempic face” could give the company a lift.
Related Posts
European Defense Stocks Face Uncertainty From Trump’s Efficiency Plans
The planned creation of a Department of Government Efficiency co-run by Elon Musk is weighing on valuations of European defense companies that rely heavily on […]
Marriott to Improve Data-Security Practices, Pay $52 Million in U.S. Settlements
The hotel operator agreed to pay a penalty and implement enhanced data-security practices as part of separate settlements with the FTC and U.S. states related […]
Office Romances Aren’t New—Why Are They Still So Complicated?
The affair between Norfolk Southern CEO Alan Shaw and an executive highlights the tricky terrain of workplace dating.